Showing 11,361 - 11,380 results of 55,503 for search '(( a ((mean decrease) OR (linear decrease)) ) OR ( a ((greater decrease) OR (largest decrease)) ))', query time: 1.12s Refine Results
  1. 11361

    Table_2_The Influence of Baseline Alzheimer's Disease Severity on Cognitive Decline and CSF Biomarkers in the NILVAD Trial.DOCX by Laila Abdullah (705077)

    Published 2020
    “…Cerebrospinal fluid Aβ42/Aβ40 ratios were increased in mild AD and decreased in moderate AD patients treated with nilvadipine, compared to their respective controls. …”
  2. 11362

    Image_1_The Influence of Baseline Alzheimer's Disease Severity on Cognitive Decline and CSF Biomarkers in the NILVAD Trial.TIF by Laila Abdullah (705077)

    Published 2020
    “…Cerebrospinal fluid Aβ42/Aβ40 ratios were increased in mild AD and decreased in moderate AD patients treated with nilvadipine, compared to their respective controls. …”
  3. 11363

    Table_1_The Influence of Baseline Alzheimer's Disease Severity on Cognitive Decline and CSF Biomarkers in the NILVAD Trial.DOCX by Laila Abdullah (705077)

    Published 2020
    “…Cerebrospinal fluid Aβ42/Aβ40 ratios were increased in mild AD and decreased in moderate AD patients treated with nilvadipine, compared to their respective controls. …”
  4. 11364

    Image_4_The Influence of Baseline Alzheimer's Disease Severity on Cognitive Decline and CSF Biomarkers in the NILVAD Trial.TIFF by Laila Abdullah (705077)

    Published 2020
    “…Cerebrospinal fluid Aβ42/Aβ40 ratios were increased in mild AD and decreased in moderate AD patients treated with nilvadipine, compared to their respective controls. …”
  5. 11365

    Image_2_The Influence of Baseline Alzheimer's Disease Severity on Cognitive Decline and CSF Biomarkers in the NILVAD Trial.TIF by Laila Abdullah (705077)

    Published 2020
    “…Cerebrospinal fluid Aβ42/Aβ40 ratios were increased in mild AD and decreased in moderate AD patients treated with nilvadipine, compared to their respective controls. …”
  6. 11366

    Image_3_The Influence of Baseline Alzheimer's Disease Severity on Cognitive Decline and CSF Biomarkers in the NILVAD Trial.TIF by Laila Abdullah (705077)

    Published 2020
    “…Cerebrospinal fluid Aβ42/Aβ40 ratios were increased in mild AD and decreased in moderate AD patients treated with nilvadipine, compared to their respective controls. …”
  7. 11367
  8. 11368
  9. 11369
  10. 11370
  11. 11371
  12. 11372
  13. 11373

    VAN-exposed lineages exhibited a fitness tradeoff in the presence and absence of vancomycin. by Samuel E. Blechman (19506884)

    Published 2024
    “…(<b>C</b> and <b>F</b>) Difference in lag time between ancestral and VAN-exposed lineages (<b><i>t</i></b><sub><b><i>0</i></b></sub> evolved–<b><i>t</i></b><sub><b><i>0</i></b></sub> ancestor) in the presence (32 μg/ml) and absence of vancomycin showed increased lag times in the absence of vancomycin and decreased lag time in the presence. For each evolved lineage, growth rate and lag time were calculated from the mean of 24 replicates. …”
  14. 11374

    Maintenance of Positive Diversity-Stability Relations along a Gradient of Environmental Stress by Tamara N. Romanuk (170380)

    Published 2010
    “…When a greater number of functional groups were present, communities were less temporally variable and achieved higher abundances. …”
  15. 11375
  16. 11376
  17. 11377
  18. 11378
  19. 11379
  20. 11380